{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T17:02:10Z","timestamp":1779123730752,"version":"3.51.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s00405-024-08954-w","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T20:19:14Z","timestamp":1725653954000},"page":"451-456","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Lipocalin-2 expression in papillary thyroid carcinoma and its association with clinicopathological characteristics"],"prefix":"10.1007","volume":"282","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0202-6979","authenticated-orcid":false,"given":"Mustafa","family":"Alkaya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0061-1755","authenticated-orcid":false,"given":"Ali","family":"Bayram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8246-6853","authenticated-orcid":false,"given":"Mehmet","family":"Ya\u015far","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8742-5014","authenticated-orcid":false,"given":"Merve","family":"Do\u011fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5081-2117","authenticated-orcid":false,"given":"H\u00fcmeyra","family":"Gen\u00e7er","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,6]]},"reference":[{"key":"8954_CR1","doi-asserted-by":"publisher","unstructured":"Sang Y, Hu G, Xue J, Chen M, Hong S, Liu R (2024) Risk stratification by combining common genetic mutations and TERT promoter methylation in papillary thyroid cancer. Endocr Feb 14. https:\/\/doi.org\/10.1007\/s12020-024-03722-6Online ahead of print","DOI":"10.1007\/s12020-024-03722-6"},{"key":"8954_CR2","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ejca.2017.02.023","volume":"77","author":"L Dal Maso","year":"2017","unstructured":"Dal Maso L, Tavilla A, Pacini F, Serraino D, van Dijk BAC, Chirlaque MD, EUROCARE-5 Working Group et al (2017) Survival of 86,690 patients with thyroid cancer: a population-based study in 29 European countries from EUROCARE-5. Eur J Cancer 77:140\u2013152. https:\/\/doi.org\/10.1016\/j.ejca.2017.02.023","journal-title":"Eur J Cancer"},{"issue":"6","key":"8954_CR3","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.surg.2013.07.008","volume":"154","author":"RH Grogan","year":"2013","unstructured":"Grogan RH, Kaplan SP, Cao H, Weiss RE, Degroot LJ, Simon CA, Embia OM, Angelos P, Kaplan EL, Schechter RB (2013) A study of recurrence and death from papillary thyroid cancer with 27 years of median follow-up. Surgery 154(6):1436\u20131446. https:\/\/doi.org\/10.1016\/j.surg.2013.07.008","journal-title":"Surgery"},{"issue":"6","key":"8954_CR4","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1089\/thy.2018.0128","volume":"29","author":"W Dong","year":"2019","unstructured":"Dong W, Horiuchi K, Tokumitsu H, Sakamoto A, Noguchi E, Ueda Y, Okamoto T (2019) Time-varying pattern of mortality and recurrence from papillary thyroid cancer: lessons from a long-term follow-up. Thyroid 29(6):802\u2013808. https:\/\/doi.org\/10.1089\/thy.2018.0128","journal-title":"Thyroid"},{"issue":"3","key":"8954_CR5","doi-asserted-by":"publisher","first-page":"202","DOI":"10.5114\/pjp.2014.45782","volume":"65","author":"H Ma","year":"2014","unstructured":"Ma H, Xu S, Yan J, Zhang C, Qin S, Wang X, Li N (2014) The value of tumour markers in the diagnosis of papillary thyroid carcinoma alone and in combination. Pol J Pathol 65(3):202\u2013209. https:\/\/doi.org\/10.5114\/pjp.2014.45782","journal-title":"Pol J Pathol"},{"issue":"1","key":"8954_CR6","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12885-017-3948-3","volume":"18","author":"R Celestino","year":"2018","unstructured":"Celestino R, Nome T, Pestana A, Hoff AM, Gon\u00e7alves AP, Pereira L, Cavadas B, Eloy C, Bj\u00f8ro T, Sobrinho-Sim\u00f5es M, Skotheim RI, Soares P (2018) CRABP1, C1QL1 and LCN2 are biomarkers of differentiated thyroid carcinoma, and predict extrathyroidal extension. BMC Cancer 18(1):68. https:\/\/doi.org\/10.1186\/s12885-017-3948-3","journal-title":"BMC Cancer"},{"issue":"1","key":"8954_CR7","doi-asserted-by":"publisher","first-page":"74","DOI":"10.7150\/ijbs.7.74","volume":"7","author":"HH Lin","year":"2011","unstructured":"Lin HH, Liao CJ, Lee YC, Hu KH, Meng HW, Chu ST (2011) Lipocalin-2-induced cytokine production enhances endometrial carcinoma cell survival and migration. Int J Biol Sci 7(1):74\u201386. https:\/\/doi.org\/10.7150\/ijbs.7.74","journal-title":"Int J Biol Sci"},{"issue":"10","key":"8954_CR8","doi-asserted-by":"publisher","first-page":"11113","DOI":"10.18632\/oncotarget.7096","volume":"7","author":"IH Chung","year":"2016","unstructured":"Chung IH, Wu TI, Liao CJ, Hu JY, Lin YH, Tai PJ, Lai CH, Lin KH (2016) Overexpression of lipocalin 2 in human cervical cancer enhances tumor invasion. Oncotarget 7(10):11113\u201311126. https:\/\/doi.org\/10.18632\/oncotarget.7096","journal-title":"Oncotarget"},{"issue":"3","key":"8954_CR9","doi-asserted-by":"publisher","first-page":"329","DOI":"10.14670\/HH-27.329","volume":"27","author":"V Barresi","year":"2012","unstructured":"Barresi V, Leni A, Tuccari G, Barresi G (2012) Neutrophil gelatinase-associated lipocalin (NGAL) immunohistochemical expression in follicular cell-derived thyroid tumors: a novel diagnostic tool? Histol Histopathol 27(3):329\u2013336. https:\/\/doi.org\/10.14670\/HH-27.329","journal-title":"Histol Histopathol"},{"issue":"1","key":"8954_CR10","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.5301\/jbm.5000245","volume":"32","author":"L Roli","year":"2017","unstructured":"Roli L, Pecoraro V, Trenti T (2017) Can NGAL be employed as prognostic and diagnostic biomarker in human cancers? A systematic review of current evidence. Int J Biol Markers 32(1):e53\u2013e61. https:\/\/doi.org\/10.5301\/jbm.5000245","journal-title":"Int J Biol Markers"},{"issue":"1","key":"8954_CR11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3322\/caac.21439","volume":"68","author":"ND Perrier","year":"2018","unstructured":"Perrier ND, Brierley JD, Tuttle RM (2018) Differentiated and anaplastic thyroid carcinoma: major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin 68(1):55\u201363. https:\/\/doi.org\/10.3322\/caac.21439","journal-title":"CA Cancer J Clin"},{"key":"8954_CR12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/b978-0-12-800263-6.00004-5","volume":"64","author":"G Lippi","year":"2014","unstructured":"Lippi G, Meschi T, Nouvenne A, Mattiuzzi C, Borghi L (2014) Neutrophil gelatinase-associated lipocalin in cancer. Adv Clin Chem 64:179\u2013219. https:\/\/doi.org\/10.1016\/b978-0-12-800263-6.00004-5","journal-title":"Adv Clin Chem"},{"key":"8954_CR13","doi-asserted-by":"publisher","first-page":"151973","DOI":"10.1016\/j.anndiagpath.2022.151973","volume":"59","author":"P Celepli","year":"2022","unstructured":"Celepli P, Bigat \u0130, Karabulut S, Celepli S, H\u00fcc\u00fcmeno\u011flu S (2022) Evaluation of Lipocalin-2 and twist expression in thyroid cancers and its relationship with epithelial mesenchymal transition. Ann Diagn Pathol 59:151973. https:\/\/doi.org\/10.1016\/j.anndiagpath.2022.151973","journal-title":"Ann Diagn Pathol"},{"issue":"6","key":"8954_CR14","doi-asserted-by":"publisher","first-page":"e0156658","DOI":"10.1371\/journal.pone.0156658","volume":"11","author":"F Rosignolo","year":"2016","unstructured":"Rosignolo F, Sponziello M, Durante C, Puppin C, Mio C, Baldan F, Di Loreto C, Russo D, Filetti S, Damante G (2016) Expression of PAX8 target genes in papillary thyroid carcinoma. PLoS ONE 11(6):e0156658. https:\/\/doi.org\/10.1371\/journal.pone.0156658","journal-title":"PLoS ONE"},{"issue":"3","key":"8954_CR15","doi-asserted-by":"publisher","first-page":"7102","DOI":"10.4238\/2014.February.21.11","volume":"13","author":"Y Wang","year":"2014","unstructured":"Wang Y, Zeng TT (2014) Clinical significance of neutrophil gelatinase-associated lipocalin (NGAL) in colorectal cancer: a meta-analysis. Genet Mol Res 13(3):7102\u20137112. https:\/\/doi.org\/10.4238\/2014.February.21.11","journal-title":"Genet Mol Res"},{"issue":"5","key":"8954_CR16","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.1007\/s13277-014-2997-3","volume":"36","author":"JM Ruiz-Morales","year":"2015","unstructured":"Ruiz-Morales JM, Dorantes-Heredia R, Arrieta O, Ch\u00e1vez-Tapia NC, Motola-Kuba D (2015) Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9) prognostic value in lung adenocarcinoma. Tumour Biol 36(5):3601\u20133610. https:\/\/doi.org\/10.1007\/s13277-014-2997-3","journal-title":"Tumour Biol"},{"issue":"1","key":"8954_CR17","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1210\/jc.2012-2528","volume":"98","author":"V Volpe","year":"2013","unstructured":"Volpe V, Raia Z, Sanguigno L, Somma D, Mastrovito P, Moscato F, Mellone S, Leonardi A, Pacifico F (2013) NGAL controls the metastatic potential of anaplastic thyroid carcinoma cells. J Clin Endocrinol Metab 98(1):228\u2013235. https:\/\/doi.org\/10.1210\/jc.2012-2528","journal-title":"J Clin Endocrinol Metab"},{"issue":"37","key":"8954_CR18","doi-asserted-by":"publisher","first-page":"14058","DOI":"10.1073\/pnas.0710846105","volume":"105","author":"A Iannetti","year":"2008","unstructured":"Iannetti A, Pacifico F, Acquaviva R, Lavorgna A, Crescenzi E, Vascotto C, Tell G, Salzano AM, Scaloni A, Vuttariello E, Chiappetta G, Formisano S, Leonardi A (2008) The neutrophil gelatinase-associated lipocalin (NGAL), a NF-kappaB-regulated gene, is a survival factor for thyroid neoplastic cells. Proc Natl Acad Sci U S A 105(37):14058\u201314063. https:\/\/doi.org\/10.1073\/pnas.0710846105","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-024-08954-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00405-024-08954-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-024-08954-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T19:54:37Z","timestamp":1736970877000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00405-024-08954-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,6]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["8954"],"URL":"https:\/\/doi.org\/10.1007\/s00405-024-08954-w","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,6]]},"assertion":[{"value":"26 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. The study protocol was approved by the institutional review board of xxx City Training and Research Hospital (01.09.2022\/698).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}